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Objective: This study modified the Revised Illness Perception Questionnaire
(IPQ-R) in patients with persistent atrial fibrillation (AF).
Design: Qualitative interviews and think-aloud techniques informed modifica-
tion of the IPQ-R to be specific to AF patients. Confirmatory Factor Analysis
(CFA) (n = 198) examined the validity of the modified IPQ-R (AF-IPQ-R).
Exploratory factor analysis (EFA) examined the new AF-triggers scale. Con-
struct validity examined associations between the AF-IPQ-R, quality of life
(QoL) and beliefs about medicines. Test–retest and internal reliability were
examined.
Results: Interviews indicated that patients viewed triggers of AF rather than
initial causes of illness as more applicable. Patients believed specific beha-
viours such as rest could control AF. Treatment control beliefs related to phar-
macological and procedural treatments. These data were used to modify the
IPQ-R subscales and to develop a triggers of AF scale. CFA indicated good
model fit. EFA of the triggers scale indicated three factors: emotional; health
behaviours; and over-exertion triggers. Expected correlations were found
between the AF-IPQ-R, QoL and treatment beliefs, evidencing good construct
validity.
Conclusion: The AF-IPQ-R showed sound psychometric properties. It pro-
vides more detailed specification than the IPQ-R of beliefs that may help to
understand poor QoL in AF patients, and guidance for future interventions in
this area.
Keywords: illness perceptions; factor analysis; IPQ-R; think aloud; persistent
atrial fibrillation; AF-IPQ-R
Introduction
Atrial fibrillation (AF) is an irregular heart rhythm affecting approximately 2% of the
general population (Go et al., 2001). AF is deemed an ‘emerging epidemic’ and diagno-
sis of AF is steadily increasing over time on an age-adjusted and an absolute basis
(Ball, Carrington, McMurray, & Stewart, 2013). AF is associated with a five-fold
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increased risk of stroke (Camm et al., 2010). Patients with AF experience symptoms
including palpitations, fatigue and dyspnoea, high levels of depression and anxiety and
poor quality of life (QoL; Dorian et al., 2000; Thrall, Lip, Carroll, & Lane, 2007). AF
accounts for 3–6% of acute hospitalisations in the UK (Lip & Tse, 2007) and costs the
National Health Service in England £459 million a year (Stewart, Murphy, Walker,
McGuire, & McMurray, 2004). Patients with persistent AF experience continuous
arrhythmia, have a higher risk of stroke, comorbidities and reduced QoL in comparison
to patients with paroxysmal AF (episodic arrhythmia which terminates in <7 days) (Chi-
ang et al., 2012).
Examining potentially modifiable factors specific to persistent AF, such as cogni-
tions or coping behaviours, and developing ways to sufficiently measure these factors,
may allow researchers to obtain a better understanding of how to improve QoL in AF.
The Common Sense Model (CSM) of illness (Leventhal, Meyer, & Nerenz, 1980) has
been widely used to examine clinical and QoL outcomes in chronic illnesses (Carnelli
et al., 2017; Hagger & Orbell, 2003; Hallas, Wray, Andreou, & Banner, 2011; Hermele,
Olivo, Namerow, & Oz, 2007; Molloy et al., 2009). According to the CSM, people con-
struct cognitive representations of illness based on abstract (disease labels) and concrete
(symptom-based) information sources. Cognitive representations then guide coping
behaviours and outcomes. Cognitive illness representations consist of several compo-
nents including identity (symptoms of the illness), cause (beliefs about precipitating fac-
tors of illness), timeline (acute, chronic, or cyclical nature of illness), consequences
(illness effects on social, psychological and physical functioning), control/cure (personal
control over illness) and illness coherence (whether the illness makes sense) (Cameron
& Leventhal, 2003; Moss-Morris et al., 2002). Emotional representations are processed
in parallel with cognitive representations which reciprocally shape patients’ cognitive
representations (Cameron & Jago, 2008). An extended CSM incorporates patients’
beliefs about treatment (treatment beliefs) which are processed alongside illness repre-
sentations (Horne, 2003).
A few studies have investigated illness representations in AF. Steed, Newman, and
Hardman (1999) conducted a cross-sectional study examining adjustment in persistent
and paroxysmal AF patients. Beliefs about the consequences of AF and illness identity
explained a high proportion of variance in adjustment. A similar cross-sectional study
in symptomatic AF patients found that greater consequences and poorer perceived
understanding of AF (illness coherence) correlated with greater psychological distress
(McCabe & Barnason, 2012). These studies suggest illness representations may predict
outcomes such as adjustment and psychological distress; however, further prospective
studies are required to confirm this. Lane, Langman, Lip, and Nouwen (2009) examined
health-related QoL in lone AF patients (paroxysmal and persistent AF patients without
structural heart damage) over 12 months and found illness identity predicted poorer
physical health.
These studies used either the original Illness Perception Questionnaire (IPQ; Wein-
man, Petrie, Moss-Morris, & Horne, 1996) or the Revised version (IPQ-R; Moss-Morris
et al., 2002) which were developed to be used with all patient groups. Although they
have shown good predictive validity across illness groups (Chilcot, Wellsted, & Farring-
ton, 2011; French, Cooper, & Weinman, 2006; Frostholm et al., 2007; Vedhara et al.,
2016), they do not allow in-depth insight into idiosyncratic beliefs held by specific
patient groups (French & Weinman, 2008). Similarly, the Brief Illness Perception



































Questionnaire (B-IPQ), a shorter nine-item measure of illness perceptions, has good
psychometric properties including predictive and discriminant validity (Broadbent, Pet-
rie, Main, & Weinman, 2006; Broadbent et al., 2015). The B-IPQ uses single item-
scales which allow rapid assessment of illness perceptions, but may lack content valid-
ity and does not sufficiently assess patients’ idiosyncratic beliefs (van Oort, Schröder,
& French, 2010). Idiosyncratic beliefs may be particularly important for designing clini-
cal interventions for specific patient groups. In a recent qualitative study, AF patients
spoke about gaining control over symptoms by avoiding activities which they believed
triggered symptoms (Taylor, O’Neill, Hughes, Carroll, & Moss-Morris, in press). The
study indicates that unhelpful coping behaviours may contribute to poor QoL in AF
patients and may be an area of focus for interventions. Although the generic IPQ, IPQ-
R and B-IPQ measure perceptions of control over the illness, they do not capture what
patients believe helps to control the illness. The latter may be more informative when
trying to alter potentially unhelpful behaviours.
The treatment control subscale of the IPQ-R also has limitations as internal reliabil-
ity of this subscale is often low (Moss-Morris et al., 2002; Chilcot, Norton, Wellsted, &
Farrington, 2012). This may be because broad questions about whether treatment can
control illness do not take into account the wide range of treatments patients may be
receiving. AF patients are likely to be taking more than one type of medication (e.g.
anticoagulants such as warfarin and antiarrhythmics such as amiodarone) and may have
several different surgical procedures. Procedures which restore normal heart rhythm
include direct current cardioversion, an electrical impulse delivered to the outside of the
chest; and catheter ablation, a more invasive procedure involving radiofrequency scar-
ring of areas of the heart generating arrhythmia (Camm et al., 2010). Cardioversion has
a high acute efficacy of 90% (Boriani et al., 2007). However, recurrence at one year is
high, with less than half of people remaining in normal sinus rhythm (Van Gelder, Cri-
jns, Van Gilst, Verwer, & Lie, 1991). Catheter ablation has a one-year success rate of
around 65%, which improves with multiple procedures to 86%. Patients on average
undergo two procedures (Ganesan et al., 2013). Atrioventricular node ablation (AVNA)
is recommended for highly symptomatic patients when AF cannot be prevented by
rhythm control strategies or pharmacological rate-control strategies (Kirchhof et al.,
2016). AVNA involves insertion of a pacemaker to control heart rate but does not cor-
rect the arrhythmia (Camm et al., 2010). The ablation itself is successful in 97.4% of
patients and AVNA is an effective therapeutic option for reducing symptoms in most
patients (Vlachos et al., 2015). To account for the diverse nature and type of treatment,
the IPQ-R may need to be adapted to represent AF-specific experiences. In addition,
successful procedures which restore normal heart rhythm are not always related to
improvements in symptom reports and QoL (Erdogan et al., 2003). A more detailed
exploration of illness representations in AF may help to understand factors contributing
to QoL after treatment.
Most modified versions of the IPQ-R focus on minor changes such as substituting
the disease label for ‘my condition’ or illness-specific additions to the causes and illness
identity subscales (French & Weinman, 2008). While the IPQ-R takes more time for
patients to complete than the B-IPQ, modifying the IPQ-R gives researchers a greater
ability to describe more elaborated beliefs which may be amenable to change in future
interventions. There are few validated modified versions of the IPQ-R but previous
studies have been completed in breast cancer survivors, cervical screening and



































musculoskeletal pain (Hagger & Orbell, 2005; Moon, Moss-Morris, Hunter, & Hughes,
2017; Nicholls, Hill, & Foster, 2012). These studies report the ability of the modified
versions to access disease-specific beliefs as a foundation to developing interventions to
support patients and provide further empirical support for the IPQ-R in different con-
texts.
The present study
This study aimed to develop a valid and reliable AF-specific version of the IPQ-R. In Part
1, the aim was to use qualitative methods to (a) modify relevant items of the IPQ-R to be
AF-specific and (b) explore the face validity of new and revised IPQ-R items using think-
aloud methods. The aim of Part 2 was to use quantitative methods to examine the validity
of the factor structure of the AF-specific IPQ-R (Atrial Fibrillation Illness Perception
Questionnaire; AF-IPQ-R), its internal and test–retest reliability, and its construct validity
in relation to AF QoL and a validated Beliefs about Medicines Questionnaire.
Part 1: Methods
Interviews were conducted as part of a broader qualitative study (inductive thematic
data reported elsewhere; Taylor et al., in press) and consisted of open-ended and semi-
structured questions. The semi-structured questions related to components of the IPQ-R
and patients’ responses to these questions informed initial modifications to the question-
naire. Face validity of the AF-IPQ-R was examined using think-aloud methods. Ethical
approval was obtained from NRES Committee North East: Newcastle and North Tyne-
side 1 (REC: 14/NE/0096).
Participants
Participants were purposively recruited from cardiology clinics and online via the AF
Association (AFA), the largest UK AF charity, before data saturation was reached, i.e.
sufficient data were collected to represent patients’ experiences (Glaser & Strauss,
2009). Eligibility criteria required patients to have a clinical diagnosis of persistent AF
and to have recently had (within 3 months), or scheduled to have their first AF procedu-
ral treatment (catheter ablation, cardioversion or AVNA). Patients with severe co-mor-
bidities were excluded (active cancer, severe heart failure and diabetes-related
hospitalisation in the past year) as these more severe illnesses may make it difficult for
patients to separate out beliefs pertinent to AF specifically.
Procedure
Clinic patients were screened for eligibility by health care practitioners (HCPs) and
given further information if they were interested in participating. AFA participants were
directed to further information about the study online and screened. Once participants
gave informed consent a telephone interview was arranged. Interviews lasted between
15 and 43 min, were transcribed verbatim and patients’ responses to the semi-structured
questions were analysed using deductive thematic analysis with the CSM as a theoreti-
cal framework.




































Thirty participants were recruited for the initial interview phase of Part 1. Participant
characteristics are summarised in Table 1. Mean age was 61.6 (SD = 11.98), over 60%
were male and the majority were white British. Themes reflected key components of
the IPQ-R (see supplementary materials Table S1). A dominant theme was that patients
felt their AF was unpredictable and could occur at any time. Patients reported specific
activities or situations which they felt triggered symptoms and targeted behavioural-re-
sponses to avoid triggers. A second theme included patients’ growing frustration and
concerns about the risks and potential ineffectiveness of treatment. These concerns
related to undergoing repeat procedures and medication side effects.
Interviews informed IPQ-R modification in three ways: (1) retention of original
items; (2) minor revisions of existing items and; (3) development of new items. Minor
revisions included wording changes in-line with recommendations for using the IPQ-R
(Moss-Morris et al., 2002) including replacing ‘my illness’ with ‘my AF’. Six AF-
specific symptoms were added to the identity scale including swollen ankles, cold
hands/feet, heart palpitations, other beating sensations, perspiration and changes in eye-
sight. Pain was modified to chest pain.
Additional minor changes were made to all other subscales, except chronic and cyc-
lic-timeline components. An item on the consequences subscale relating to financial
consequences of illness was removed and replaced with consequences to work life
which was more consistent with patients’ reports that AF symptoms affected work life,
including promotions and socialising with colleagues. The coherence subscale was mod-
ified to reflect treatment as well as illness coherence (I have a clear understanding of
my AF and my treatment for it) as some patients reported poor understanding of treat-
ment, particularly relating to procedures and warfarin. A new coherence item was
developed reflecting patients’ beliefs that it was unnecessary to understand AF or treat-
ment (I don’t feel the need to understand my AF or my treatment for it). For the emo-











30 6 198 26
Age mean (SD) 61 (12) 60 (12) 64 (9) 63 (12)
Sex n(%)
Female 11 (37) 1 (17) 46 (23) 5 (19)
Ethnicity n(%)
White British 29 (97) 6 (100) 192 (97) 35 (100)




Cardioversion 11 (37) 2 (33) 116 (59) 17 (65)
Catheter ablation 10 (33) 2 (33) 71 (36) 9 (35)
AVNA 9 (30) 2 (33) 11 (5) 0 (0)
Note: SD, Standard Deviation. AVNA, AV node ablation.



































tional representation subscale, anger and feeling afraid were replaced with frustration
and worries about heart dysfunction.
More significant changes were made to the causes scale. Patients viewed AF as
recurrent and believed certain events or behaviours could trigger AF symptoms. A
symptomatic triggers scale appeared more relevant than examining patients’ beliefs
about the original cause of AF which was seldom mentioned. The stem to the casual
scale was therefore altered to reflect which factors they believed triggered AF symptoms
rather than caused AF. Based on the interviews, four new items were added to the AF
triggers scale including exercise, caffeine, other cardiovascular illness and medication,
to give a 16-item scale.
The unpredictability theme relates to the personal control subscale and led to the
development of new items. An item (the course of my illness depends on me) was
removed and replaced with an item which captured patients’ struggles to gain control
over unpredictable symptoms (my AF symptoms are unpredictable and my control over
them varies). Patients held beliefs that targeted behaviours could control symptoms such
as slowing down, resting and avoiding activities. This led to three additional personal
control items: By doing less and slowing down I can control whether I have AF symp-
toms; Resting will prevent me from having symptoms; Avoiding certain activities will
control my AF. Finally, treatment control items were re-worded to relate specifically to
the pharmacological and procedural treatments which patients were undergoing (includ-
ing catheter ablation, AVNA, cardioversion, antiarrhythmics and anticoagulants).
Think-aloud modifications
A sub-set of six participants from the qualitative study (Table 1) were asked to review
the first draft of the modified-IPQ-R using think-aloud methods. This allowed us to
ascertain whether items were likely to be interpreted as we intended (i.e. face validity).
Think-aloud analysis has been used to modify the IPQ-R in patients with Type 2 dia-
betes, breast cancer and in children of patients with multiple sclerosis (Bogosian, Moss-
Morris, Bishop, & Hadwin, 2014; McCorry, Scullion, McMurray, Houghton, & Demp-
ster, 2013; Moon et al., 2017). Participants were given the modified questionnaire and
asked to read each item aloud during telephone interviews. Participants talked through
how they would answer each question, whether the question was clear and understand-
able and gave their overall thoughts of the questionnaire. Interviews were audio-
recorded and lasted between 16 and 40 min. Adopted changes to the questionnaire were
based on the frequency of participants’ comments relating to specific items and per-
ceived relevance. Changes were discussed and agreed between two researchers.
Think-aloud interviews indicated that patients understood the questionnaire and that
it had acceptable face validity. Changes were made to improve clarity on the illness
coherence component. An item within the triggers scale was expanded upon to provide
further context (my own behaviour e.g. pushing myself too hard). Some reverse items
were outlined as problematic but participants could ascertain intended responses so no
changes were made. Repetitive items were reworded or removed. The modified-IPQ-R
(AF-IPQ-R) is available in Supplementary Materials (Figure S1).



































Part 2: Quantitative methods
Part 2 consisted of a cross-sectional questionnaire study which examined the factor
structure and validity of the AF-IPQ-R. Ethical approval was obtained from NRES
Committee London Bloomsbury (14/LO/2148).
Participants
Patients with a clinical diagnosis of persistent AF who were undertaking a procedural
treatment (catheter ablation, cardioversion or AVNA) were eligible to participate. As
described in Part 1 above, people with severe co-morbidities were excluded. A total of
198 participants were recruited from cardiology clinics (n = 174) and online from the
AFA (n = 24). See Supplementary Materials Figure S2 for recruitment rates. The sample
was in line with recommendation of at least 100 participants for factor analyses (Cattell,
1978). Mean age, gender, ethnicity and treatment type were very similar between clinic
and AFA patients. A sub-set of this sample (see Table 1) participated in the test–retest
reliability. These patients were opportunistically selected and agreed to be contacted
two weeks after completing the baseline questionnaire and had not undertaken proce-
dures.
Measures
Demographic and illness factors were examined including age, gender, ethnicity and
treatment type (Table 1). Measures were included in a single questionnaire pack:
The AF-IPQ-R has a three-part structure. The first part measures illness identity. Par-
ticipants rate whether they have experienced a list of 20 symptoms and if they believe
each symptom is related to their AF. The latter is summed to provide an identity score.
The second part consists of items measuring chronic-timeline (six items), cyclic-timeline
(four items), consequences (six items), illness coherence (six items), personal control
(nine items), treatment control (five items) and emotional representations (six items).
The last 16-item scale examines AF triggers. A five-point Likert-type scale ranging
from ‘strongly disagree’ to ‘strongly agree’ is used to score components.
The Atrial Fibrillation Effect on Quality of Life Questionnaire (AFEQT; Spertus
et al., 2010) is a 20-item AF-specific QoL measure routinely used in clinical practice. It
assesses symptoms (four items), activities (eight items) treatment concern (six items)
and treatment satisfaction (two items). The first three components are summed to pro-
vide an overall health score. A seven-point Likert-type scale ranging from ‘not at all’ to
‘extremely limited’ is used in all components. It has shown good reliability in AF
patients undergoing different treatments, acceptable test–retest reliability and good con-
struct validity in relation to other AF-specific QoL questionnaires (Dorian et al., 2013).
The Beliefs about Medicines Questionnaire (BMQ)-Specific (Horne, Weinman, &
Hankins, 1999) measures beliefs using two factors: concerns (5 items) and necessity (5
items) of medication. In the current study, beliefs were examined in relation to AF-
specific procedures (cardioversion, catheter ablation and AVNA). Responses are made
using a five-point Likert-type scale; ‘strongly disagree’ to ‘strongly agree’. The BMQ-
general scales measure attitudes to medicines generally and was not used in the current
study as the BMQ-Specific is a better predictor of outcomes in patients with long-term



































conditions (Horne et al., 2013). The BMQ-Specific has been validated in a range of
chronic illnesses including cardiac patients and shows good reliability and discriminant
validity.
Procedure
Patients were approached by HCPs at cardiology clinics. If they were interested in the
study, they were given an information sheet and consent form to read and given the
option to discuss the study further with a researcher. Patients who agreed to participate
gave informed consent and were invited to complete the questionnaire in clinic or to
return it later by pre-paid post. AFA patients were directed from the AFA website to an
electronic copy of the information sheet, consent form and questionnaire. Patients par-
ticipating in the test–retest reliability study were invited to complete the questionnaire
again after two weeks and were sent a copy of the questionnaire by post.
Statistical analysis
Confirmatory factor analysis (CFA)
Mean imputation was used to account for missing data as there was less than 5% miss-
ing. A CFA was conducted on the AF-IPQ-R using MPlus (V.7) and is the analytic tool
of choice when refining measurements (Brown, 2014; Schreiber, Nora, Stage, Barlow,
& King, 2006). The seven-factor hypothesised model was estimated to examine the
components of chronic-timeline, cyclic-timeline, consequences, personal control, treat-
ment control, illness coherence and emotional representations. Individual items were
specified to load on hypothesised components. As the authors of the original IPQ-R
indicate a co-variation between illness-representation components, intercorrelations
between variables were examined.
Weighted Least Squares with Mean and Variance adjustment estimation (WLSMV)
were used to account for continuous and categorical data (Brown, 2014). To assess
model fit, the root mean square of approximation (RMSEA), comparative fit index
(CFI) and Tucker–Lewis index (TLI) were used (Jackson, Gillaspy, & Purc-Stephenson,
2009). These fit indices are designed to overcome problems associated with small sam-
ple size in comparison to indices such as chi-squared (Schreiber et al., 2006). An
RMSEA value of less than .08 and TLI and CFI values greater than .95 indicate reason-
able fit (Hu & Bentler, 1999). Standardised factor loadings were used in case of model
mis-specifications and large residuals indicating lack of reliability were removed from
the data (Brown, 2014). The CFA was an iterative process although modifications were
done sparingly and only when theoretically plausible (Jackson et al., 2009).
Exploratory factor analysis for triggers scale
An exploratory factor analysis (EFA) was conducted on the 16-item triggers scale to
examine the underlying factor structure and latent variables. The EFA was conducted in
SPSS (V.22) using maximum-likelihood extraction and oblique rotation (direct oblimin)
as factors were expected to correlate.



































Reliability and construct analyses
Reliability analyses were conducted in SPSS (V.22) on the AF-IPQ-R. Cronbach’s coef-
ficient alpha (α) tested internal consistency. Test–retest reliability was conducted using
intra-class correlation coefficients (ICC) over a two-week period as recommended by
Marx, Menezes, Horovitz, Jones, and Warren (2003). An ICC can vary between 0 and
1.0 where 1.0 indicates perfect reliability. Bland–Altman plots examined the generalis-
ability of test–retest reliability and potential outliers (Bland & Altman, 1986). Construct
validity examined the interrelationships between AF-IPQ-R subscales with the BMQ
(Horne et al., 1999) and AFEQT (Spertus et al., 2010).
Results
Identity scale
Symptoms most commonly associated with AF were breathlessness, fatigue, heart palpi-
tations, dizziness and loss of strength. This is consistent with symptoms reported in the
literature and supports the inclusion of AF-specific symptoms (See Supplementary
Materials Table S2). The mean number of symptoms attributed to AF was 6.6
(SD = 3.3).
Confirmatory factor analysis
Initial CFAs were run individually for each scale of the AF-IPQR to eliminate items
with low factor loadings. Removed items included three items on personal control:
IPQR14 (My AF symptoms are unpredictable and my control over them varies);
IPQR15 (Nothing I do will affect my AF); IPQR17 (My actions will have no effect on
the outcome of my AF), one illness coherence item: IPQR27 (I don’t understand my AF
or treatment), and one chronic-timeline item: IPQR21 (My AF will improve in time). At
this stage, poor model fit was indicated when conducting a single CFA for the treatment
control subscale; however, factor loadings of .35 (lower than the recommended .4) and
above were retained as removal led to worse loadings.
A full-factor analysis was conducted on the AF-IPQ-R which yielded an RMSEA of
.063, CFI = .918 and TLI = .910. Data were visually inspected and showed that items
correlated according to the subscales of the IPQ-R suggesting appropriate use of a
CFA. IPQR16 (I have the power to influence my AF) (personal control) was removed
due to factors loadings of less than .35. The final AF-IPQ-R showed good model fit:
RMSEA = .063, CFI = .923 and TLI = .915. Factor loadings of the final CFA can be
found in Table 2. Factor loadings ranged from .35 to .93. Beliefs about treatment
control relating to procedures and to medication did not load onto the same scale and
were therefore treated as separate scales. The highest factor loadings across the
AF-IPQ-R came from two of the three newly developed personal control items which
reflected specific rather than general control beliefs, as well as an item on poor illness
coherence.



































Table 2. Confirmatory factor analysis of the Atrial Fibrillation Illness Perception Questionnaire
(AF-IPQ-R) items (excluding identity and trigger items) and factor loadings of final model.
IPQ-R item number and component 1 2 3 4 5 6 7
Timeline (chronic/acute)
1 My AF will last for a short time .73
2 My AF symptoms are likely to be permanent rather than
temporary permanent
.76
3 My AF will last a long time .90
4 This AF will pass quickly .80
5 I expect to have AF for the rest of my life .71
21 My AF will improve in time R
Consequences
6 My AF is a serious condition .66
7 My AF has major consequences on my life .83
8 My AF does not have much effect on my life .70
9 My AF strongly affects the way others see me .56
10 My AF affects my working lifea .61
11 My AF causes difficulties for those who are close to me .72
Personal control
12 There is a lot which I can do to control my AF
symptoms
.38
13 The things I do are likely to make my symptoms better
or worse
.41
14 My AF symptoms are unpredictable and my control over
them variesb
R
15 Nothing I do will affect my AF R
16 I have the power to influence my AF R
17 My actions will have no effect on the outcome of my
AF
R
18 By doing less and slowing down, I can control whether
I have AF symptomsb
.74
19 Resting will prevent me from having symptomsb .90
20 Avoiding certain activities will control my AFb .89
Illness coherence
22 The symptoms of my AF are puzzling to me .81
23 My AF is a mystery to me .86
24 I don’t understand my AF .93
25 My AF doesn’t make any sense to me .85
26 I have a clear understanding of my AF and my
treatment for it cleara
.49




28 My AF symptoms change a great deal from day to day .79
29 My AF symptoms come and go in cycles come/go .82
30 AF is very unpredictable .70




32 I get depressed when I think about my AF .86
33 When I think about my AF I get upset .89
34 My AF makes me feel frustratedb .67
(Continued)



































EFA for triggers scale
Preliminary interpretation
To determine if any items may be redundant, ceiling effects were tested by examining
item frequencies to ascertain whether 80% or more participants disagreed with any
specified items on the trigger scale. No items were removed on this basis. The most
commonly attributed triggers of AF included stress/worry (54%), own behaviour (51%)
and exercise (49%) (See Supplementary Materials Table S3). Inspection indicated a pat-
terned relationship amongst variables except for IPQRT4 (chance) which was removed.
Bartlett’s Test of Sphericity χ²(105) = 1106.44, p < .001 further confirmed patterned
relationships between items. Haitovsky’s test indicated that data did not have any issues
of multicollinearity (p < .001). Kaiser–Meyer–Olkin Measure (KMO) was .84 indicating
the data were suitable for EFA.
Factor extraction and rotation
Using Kaiser’s criterion, an eigenvalue of 1.0 cut-off and visual inspection of the scree
plot, three meaningful factors were indicated. Factors were labelled as (1) Emotional
Triggers, which contained items related to stress and emotional state, (2) Over-exertion
triggers including exercise and over-work, and (3) Health Behaviour triggers including
health-specific behaviours such as smoking and co-morbid conditions. See Table 3 for
factor loadings. Good model fit was indicated with 27% of the non-redundant residuals
with absolute values greater than .05. Factors moderately correlated: Emotional Triggers
positively correlated with Health Behaviour triggers (r = .52) and Over-exertion triggers
(r = .53). Health Behaviour triggers and Over-exertion triggers were less correlated
(r = .39).
Table 2. (Continued).
IPQ-R item number and component 1 2 3 4 5 6 7
35 My AF does not worry me .55
36 Having AF makes me feel anxious .69




38 There is very little that can be done to improve my AF/
reduce my risk of stroke
.43
39 My treatment* will be effective in curing my AF/
reducing my risk of strokea
.78
40 My treatment* will stop my AF from coming back/me
from having a strokeb
.59
41 My treatment* can control my AF symptoms/my stroke
riska
.69
42 There is nothing which can help my AF symptoms/stop




Note: R, removed item.
*The treatment control component was phrased to relate specifically to relevant procedural (cardioversion,
catheter ablation, atrioventricular node ablation) and pharmacological (antiarrhythmic drugs, anticoagulant
drugs) treatments.



































Test–retest and internal reliability (Cronbach’s alpha)
The AF-IPQ-R subscales showed acceptable internal reliability. Cronbach’s alphas ran-
ged from .86 to .63 (Table 4). On average, patients took 20 days (range of 13–24 days)
to return the two-week questionnaires for the test–retest analysis. ICC scores ranged
from .82 to .58 and showed acceptable test–retest reliability and stability of constructs
over time for all subscales (Table 4). Further analysis of test–retest reliability using
Bland–Altman plots showed that there were large variations in patients’ responses for
the chronic-timeline component, indicating lack of consistency in responses over time,
which were not highlighted by ICC score. Bland–Altman plots also revealed systematic
Table 3. Table showing results from EFA of the AF-IPQ-R triggers scale.
Item description
Factor 1 Factor 2 Factor 3
Emotional triggers Health behaviour triggers Over-exertion triggers
Emotional state .82 .00 .01
Mental attitude .70 .04 .03
Family problems .66 .01 .14
Personality .56 .12 .07
Stress/worry .45 .04 .30
Alcohol .10 .80 .02
Smoking .01 .72 .01
Caffeine .08 .62 .10
Cardiovascular .01 .62 .01
Immune system .18 .54 .07
Medication .27 .47 .05
Diet/eating habits .10 .47 .01
Own behaviour .01 .05 .92
Overwork .23 .04 .52
Exercise .01 .20 .43
Eigenvalues 5.07 1.30 .66
% of variance 33.80 8.70 4.40
Note: Bold items indicate items loading on factors.
Table 4. Results for test–retest reliability for the Atrial Fibrillation Illness Perception Question-
naire (AF- IPQ-R).
AF-IPQ-R component Cronbach’s alpha (α) Test-retest ICC (95% CI)
Chronic timeline .84 .58
Consequences .77 .64
Personal control .76 .60
Illness coherence .86 .66
Cyclic timeline .83 .60
Emotional representations .81 .79
Treatment control .63 .68
Identity N/A .57
Emotional triggers .84 .82
Health behaviours triggers .82 .58
Over-exertion triggers .71 .69
Note: ICC, intraclass correlation coefficient. CI, confidence interval. N/A, analysis not conducted on identity.



































bias over time for the illness coherence component which indicated that in most
patients, illness coherence increased over the two weeks.
Construct validity
Intercorrelations can be seen between AF-IPQ-R components in Supplementary Materi-
als (Table S4). Correlations were in line with hypothesised relationships; emotional rep-
resentations were strongly positively correlated with serious consequences. Cyclic-
timeline positively correlated with illness identity, personal control, consequences, and
all triggers (emotional, health behaviours and over-exertion). Cyclic-timeline was nega-
tively correlated with coherence. Treatment control and personal control were uncorre-
lated, indicating the relevance of separate control measures.
Expected correlations were also found between the AF-IPQ-R and AF-specific QoL
(AFEQT) and procedural treatment beliefs (BMQ) (Table 5): QoL negatively correlated
with identity, consequences, cyclic-timeline, emotional representations, emotional trig-
gers and overexertion triggers. Unexpectedly, personal control was also negatively cor-
related with QoL. A small positive correlation was found between illness coherence and
QoL. Procedural necessity correlated positively with consequences, identity and proce-
dural treatment control. Procedural concerns negatively correlated with illness coherence
and treatment control and positively correlated with cyclic timeline, emotional represen-
tations and all triggers.
Discussion
Initial interviews completed as part of this study suggested the IPQ-R needed to be
modified and extended to capture more specific features of AF patients’ illness beliefs.
Modifications included replacing the causes scale with a AF symptom triggers scale,
relating the treatment control component to specific AF pharmacological and procedural
treatments, and the addition of three personal control items related to beliefs about
Table 5. Correlations between AF-IPQ-R, quality of life (AFEQT) and beliefs (concerns and
necessity) about treatment (BMQ).
AFEQT QoL BMQ concerns BMQ necessity
Identity −.39** .07 .30**
Chronic timeline −.06 .08 −.10
Cyclic timeline −.35** .22** .18*
Consequences −.57** −.16* .50**
Illness coherence .17* −.36** −.04
Personal control −.15* .16* .27**
Procedural treatment control .02 −.17* .40**
Emotional representations −.39** .30** .32**
Emotional triggers −.27** .34** .21**
Health behaviour triggers −.13 .28** .11
Overexertion triggers −.30** .23** .23**
Note: QoL, quality of life.
*p < .05.
**p < .01.



































reducing activity to control AF symptoms. Factor analysis helped to reduce the scale to
best fit items and confirmed the factor structure of this revised scale which was also
shown to have good internal reliability and moderate test–retest reliability. Construct
validity was confirmed.
Moderate test–retest ICC scores may be due to the unpredictable nature of AF influ-
encing some beliefs such as personal and treatment control and chronic timeline. For
instance, if the AF-IPQ-R is administered when patients feel symptom-free, they may
rate the control and timeline of their illness more positively than at a time when they
are experiencing symptoms. This was supported by Bland–Altman plots which indicated
systematic change in treatment control beliefs which may have increased as an artefact
of participating in the study, or because patients sought a better understanding of AF
with upcoming procedures. A systematic review of the IPQ-R used in musculoskeletal
disorders also found moderate test–retest reliability and suggested that in illnesses
where symptoms fluctuate, illness representations may not remain stable (Leysen et al.,
2015). Emotional representations was the most stable construct, as found in previous
research examining internal reliability of the IPQ-R (Moon et al., 2017), and may indi-
cate emotional representations about AF are more stable than cognitive representations.
The AF-IPQ-R showed good construct validity in relation to the interrelationships
between the subscales, necessity and concern beliefs about procedures (measured by the
BMQ) and QoL (measured by the AFEQT). Correlations were largely congruent with
previous research (Moon et al., 2017; Moss-Morris et al., 2002; Snell, Siegert, Hay-
Smith, & Surgenor, 2010). Within the AF-IPQ-R subscales, the belief that AF is a
cyclical condition was related to greater emotional representations. Contrary to previous
research, believing AF to be cyclic was related to greater personal control. It may be
that individuals who experience unpredictable symptoms believe they result from speci-
fic behaviours and are controllable by engaging in specific personal control behaviours.
This can be supported by the finding that behaviours such as overwork or exercise are
perceived as AF triggers.
The study also confirmed the relationship between illness representations as measured
by the AF-IPQ-R and QoL in AF. Attributing more symptoms to AF, holding beliefs that
AF is recurrent and has greater consequences on everyday life, and having greater emo-
tional representations about AF, was associated with poorer QoL. Interestingly, patients
who held greater personal control beliefs also experienced poorer QoL. Rather than hold-
ing general personal control beliefs, AF patients may believe that specific, targeted beha-
viours can control symptoms, as evidenced by high factor loadings on the specific
personal control component. To gain control of symptoms, patients may feel it is neces-
sary to continuously assess their own behaviours to find out which behaviours they per-
ceive to be associated with worsened symptoms. In turn, constant control efforts may be
associated with beliefs that AF has greater consequences on everyday life. In addition,
personal control was measuring control through limiting activity and doing less.
Although personal control is often viewed as a positive correlate of good outcome,
believing illness should be controlled by doing less appears to be negatively associated
with outcome. Specific personal control behaviours may involve relinquishing activities
(avoidance), contributing to poorer perceived QoL. Previous research indicates that
engaging in avoidance behaviours is associated with illness-chronicity and mortality in
patients with heart failure and irritable bowel syndrome (Murberg, Furze, & Bru, 2004;
Spence & Moss-Morris, 2007). While the current study indicates that AF patients believe



































specific behaviours can control symptoms, further research is needed to examine whether
AF patients actually engage in these specific behaviours, and if so, should identify poten-
tial helpful behaviours which may improve QoL.
While the current study supports the CSM, interrelationships between the dimen-
sions of cognition representations and emotional representations suggest these are inter-
acting features of the model rather than parallel pathways as outlined in the original
model (Leventhal et al., 1980). Negative emotional representations may result from per-
ceived ineffectiveness of coping behaviours to reduce AF symptoms and perceptions
that AF is uncontrollable. Stability of emotional representations evidenced in the current
study indicates that negative emotional representations may be more resistant to change
than cognitions, which should be considered when designing interventions. In addition,
treatment beliefs may develop based on previous experiences of AF and established ill-
ness perceptions. For instance, even when treatment is successful in restoring normal
sinus rhythm, patients’ previous experiences and cognitive representation of AF as
uncontrollable may lead to beliefs that treatment will be ineffective in controlling AF.
This may result in continued coping behaviours such as avoidance and negative emo-
tional representations. Longitudinal studies examining the direction of relationships are
needed to investigate these potential pathways.
The strength of the current study is that a thorough process informed the initial modi-
fication of the AF-IPQ-R and robust statistical analyses were used for validation. In addi-
tion, different samples were used in the development (interviews) and validation (factor
analyses) of the AF-IPQ-R. One limitation of the study is that the AF-IPQ-R is only vali-
dated in persistent AF patients so although it is likely the AF-IPQ-R would apply to
patients with other types of AF, further validation across other types of AF is required to
support the factor structure in the context of all AF patients. As users of an online support
group, AFA patients may be more motivated to discuss their experiences than clinic
patients, as reflected by a higher percentage of questionnaire completion in AFA patients.
Overall, recruitment rates were low (47%). This may be due to strict eligibility criteria as
patients were required to return questionnaires prior to procedures. In addition, although
severe co-morbidities were excluded, AF patients are likely to have other co-morbidities
and invasive symptoms which may have inhibited the completion of questionnaires.
Lastly, although the current study considers AF-specific treatments, further facets of treat-
ment representations may exist. Future research should examine beliefs about the risk
and side-effects of treatment and treatment coherence, which may influence coping and
QoL outcomes (Horne, 2003; Karamanidou, Weinman, & Horne, 2008).
In summary, the qualitative component of this study supported modifying the IPQ-R
in AF patients. The original IPQ-R would not have assessed the idiosyncratic beliefs
held by AF patients which the AF-IPQ-R captures, including beliefs related to the trig-
gers of AF symptoms, specific ways to control recurrence of symptoms and procedural
treatment beliefs. The AF-IPQ-R is a psychometrically sound tool which can be used to
examine theoretical relationships in the context of the CSM. These data can be used to
target modifiable CSM-related cognitions, emotions and behaviours to inform interven-
tions to address AF-specific issues such as poor adherence to warfarin which increases
stroke risk (Kimmel et al., 2007). These studies could also inform the development of
interventions to identify unhelpful illness perceptions which may be associated with
distress and poor QoL and to reduce unhelpful behavioural responses to symptoms such
as avoidance or unnecessary healthcare utilization.
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